For the second time in three years, Mallinckrodt has filed for Chapter 11 bankruptcy protection in the US, striking in the process a deal with its creditors that will more than halve the $1.7bn the firm had previously agreed to pay to settle claims over its role in the US opioid crisis.
Following Mallinckrodt’s initiation of voluntary prepackaged Chapter 11 proceedings in the US Bankruptcy Court for the District of Delaware, the company will move on a restructuring support agreement (RSA) previously entered into with more than 85% of each of